Patient characteristics determining rHuEPO dose requirements

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 5, 2002, Pages 38-41

  Ifudu, Onyekachi ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

Age; Anaemia; Dialysis; Erythropoiesis; Erythropoietin; ESRD; Gender; Haemodialysis; Intravenous iron; Race; Sex; URR

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIABETES MELLITUS; DISEASE DURATION; DOSE RESPONSE; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; NUTRITIONAL STATUS; PREGNANCY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; VASCULAR ACCESS; AGE; BLOOD; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; RENAL REPLACEMENT THERAPY; REVIEW; SEXUAL DEVELOPMENT;

AGE FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NUTRITIONAL STATUS; RENAL DIALYSIS; SEX CHARACTERISTICS;

EID: 0036311998     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_5.38     Document Type: Article

References (40)

1. Hematocrit levels and hospitalization risks in hemodialysis patients
2. Hematocrit level and associated mortality in hemodialysis patients
3. Economic implications of inadequate response to erythropoietin in end-stage renal disease
4. Anemia in hemodialysis patients: Variables affecting this outcome predictor
5. Clinical Practice Guidelines for the treatment of anemia of chronic renal failure
6. Adequacy of dialysis and differences in hematocrit among dialysis facilities
7. Racial vs ethnic analysis of selected intermediate outcomes for hemodialysis patients: Results from the 1997 ESRD Core Indicators Project
8. Gender modulates responsiveness to recombinant erythropoietin
9. Role of type of vascular access in erythropoietin and intravenous iron requirements in hemodialysis
10. Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients
11. Specific problems of renal anemia in childhood
12. Renal anemia in children. A review
13. Aging and hematopoiesis. Implications for treatment with haemopoietic growth factors
14. Recombinant hemopoietic growth factors: Comparative hemopoietic response in younger and older subjects
15. Erythropoietin response to anemia as a function of age
16. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: The effects of age and gender
17. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups
18. The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women
19. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses
20. Influence of hormones on the release of iron by macrophages
21. Relationship among plasma iron, plasma iron turnover, and reticuloendothelial iron release
22. Plasma iron turnover in normal subjects
23. Iron metabolism in reticuloendothelial cells
24. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland
25. The anemia in continuous ambulatory peritoneal dialysis patients is related to Kt/V index
26. Residual renal function modulates response to erythropoietin in chronic renal insufficiency
27. Factors, limiting the eythropoietin response in rapidly growing infants with congenital nephrosis on a peritoneal dialysis regimen after nephrectomy
28. Death risk and anemia in ESRD-low hematocrit is a surrogate for malnutrition inflammation
29. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy
30. Anemia due to reduced serum erythropoietin concentration in non-uremia diabetic patients
31. Blunted erythropoietin response to anemia in type 1 diabetic patients
32. Diabetes increases the severity of anemia in non-dialyzed patients with renal failure
33. Erythropoietin depletion and anaemia in diabetes mellitus
34. Increased erythrpoietin requirements in patients with failed renal transplants returning to a dialysis program
35. Hepatitis B virus infection and the response to erythropoietin in end-stage renal disease
36. Hepatitis-related hepatic erythropoietin production
37. Erythropoiesis associated with viral hepatitis in end-stage renal disease
38. Erythropoietin in polycyctic kidneys
39. Use of recombinant erythropoietin in thalassemic patients on dialysis